Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DX25F6XPS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $17,358
Award facts
- Contract value 100% obligated
- $17,357.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $17,357.75 on July 29, 2025, for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, which must be completed by August 19, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a certified woman-owned small business. The products will be delivered to Park Ridge, Illinois, and funded through the Medical Supply Chain within the Department of Defense.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, supporting Department of Defense healthcare facilities nationwide. The company's robust IDC with the DLA, valued at $499,999,999 through November 2026, enables the agency to issue delivery orders across an extensive portfolio of pharmaceutical products including prescription medications, biologics, and medical consumables. This particular delivery order for Nexplanon implants—a long-acting contraceptive device—reflects the company's role in providing specialized pharmaceutical products to military health systems and demonstrates the efficiency of the DLA's streamlined procurement vehicle for recurring medical supply needs.
Quick answers
Who was awarded contract SPE2DX25F6XPS?
SPE2DX25F6XPS was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 29, 2025.
How much is contract SPE2DX25F6XPS worth?
The government has obligated $17,358 on SPE2DX25F6XPS.
Is contract SPE2DX25F6XPS an order under another contract?
Yes. SPE2DX25F6XPS is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XPS competed?
The extent of competition for SPE2DX25F6XPS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award